Ramucirumab or placebo plus erlotinib in EGFR ‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY

  • Makoto Nishio, Takashi Seto, Martin Reck, Edward B. Garon, Chao‐Hua Chiu, Kiyotaka Yoh, Fumio Imamura, Keunchil Park, Jin‐Yuan Shih, Carla Visseren‐Grul, Bente Frimodt‐Moller, Annamaria Zimmermann, Gosuke Homma, Sotaro Enatsu, Kazuhiko Nakagawa
  • Cancer Science, October 2020, Wiley
  • DOI: 10.1111/cas.14655

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/cas.14655

The following have contributed to this page: Satoshi Ikeda